EBOS Group completes A$200m placement to fund growth
EBOS Group Limited (NZX:EBO) announced the successful completion of an approximately A$200 million fully underwritten placement of new ordinary shares. The placement, involving approximately 5.9 million new shares priced at NZ$36.65 each, aims to fund acquisitions, including SVS Veterinary Supplies, and the remaining stake in Transmedic, while also providing additional balance sheet capacity for future growth. Strong support from both existing and new investors across New Zealand, Australia, and offshore facilitated the placement's completion. Eligible shareholders who bid for their pro rata share have been allocated their full bid. Trading of EBOS shares recommenced on the NZX, with settlement expected on April 16 and 17 for ASX and NZX, respectively. EBOS intends to conduct a retail offer to eligible existing shareholders to raise up to A$50 million, with the ability to accept oversubscriptions at EBOS' discretion. This placement also required a trading halt.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Ebos Group publishes news
Free account required • Unsubscribe anytime